Study of Integrative Chinese and Western Medicine Management for COPD and Related Conditions in Adults Aged 40 to 80

What this Trial Is About

Chronic obstructive pulmonary disease COPD is a common long-term respiratory condition often accompanied by other health problems. This research aims to gather real-world data on managing COPD alongside these additional conditions using a combination of Chinese and Western medicine approaches. The study focuses on understanding risk factors for high-risk groups and patients with confirmed comorbidities, developing models to predict risks of comorbidities and acute COPD flare-ups, and improving long-term care strategies with early detection across hospitals, communities, and homes. Participants will receive routine clinical care following current guidelines, with no study-mandated treatments assigned. Data will be collected through standard clinical evaluations such as symptom questionnaires, lung function tests, imaging, and biomarker analysis. Additionally, continuous multisensor digital monitoring will track heart rate, blood pressure, activity, sleep, and other physiological and behavioral signs. Traditional Chinese Medicine assessments including tongue, pulse, and facial diagnostics will also be performed to provide comprehensive digital phenotyping. Throughout the study, participants will be regularly assessed by clinical tests, questionnaires, and continuous monitoring devices. Researchers will measure the annual rate of COPD exacerbations and the occurrence of related comorbidities such as hypertension, heart disease, arrhythmia, heart failure, and diabetes over up to 36 months. This extensive monitoring aims to support evidence-based management and early warning systems for COPD with comorbidities. The total study duration and follow-up will be up to three years.

IMPACT COPD Cohort (China)